Effects of Travoprost on Neovascular Glaucoma
Overview
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Double
Interventions
- Drug: Travoprost
Clinical Trial Outcome Measures
Primary Measures
- Intraocular pressure
Secondary Measures
- Inflammation
Participating in This Clinical Trial
Inclusion Criteria
- Neovascular glaucoma of known cause – Older than 18 years – Previously submitted to retinal photocoagulation – Under medical treatment to glaucoma Exclusion Criteria:
- Need of antiglaucomatous surgery – Previous ocular surgery in the last 6 months – Pregnancy
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Federal University of São Paulo
- Overall Official(s)
- Luiz A Melo Jr, MD, Principal Investigator, Federal University of São Paulo
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.